Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity.
Kotanides H, Li Y, Malabunga M, Carpenito C, Eastman SW, Shen Y, Wang G, Inigo I, Surguladze D, Pennello AL, Persaud K, Hindi S, Topper M, Chen X, Zhang Y, Bulaon DK, Bailey T, Lao Y, Han B, Torgerson S, Chin D, Sonyi A, Haidar JN, Novosiadly RD, Moxham CM, Plowman GD, Ludwig DL, Kalos M.
Kotanides H, et al. Among authors: chin d.
Cancer Immunol Res. 2020 Oct;8(10):1300-1310. doi: 10.1158/2326-6066.CIR-20-0304. Epub 2020 Jul 27.
Cancer Immunol Res. 2020.
PMID: 32873605